<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" version="2.0">

<channel>
	<title>MGH Center for Women's Mental Health</title>
	
	<link>http://www.womensmentalhealth.org</link>
	<description>MGH Center for Women's Mental Health</description>
	<lastBuildDate>Fri, 25 May 2012 00:47:45 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/womensmentalhealth/mgh" /><feedburner:info xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" uri="womensmentalhealth/mgh" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item>
		<title>Yaz and Other Oral Contraceptives Will Carry a New Warning Label</title>
		<link>http://www.womensmentalhealth.org/posts/yaz-and-other-oral-contraceptives-will-carry-a-new-warning-label/</link>
		<comments>http://www.womensmentalhealth.org/posts/yaz-and-other-oral-contraceptives-will-carry-a-new-warning-label/#comments</comments>
		<pubDate>Thu, 24 May 2012 08:02:54 +0000</pubDate>
		<dc:creator>MGH Center for Women's Mental Health</dc:creator>
				<category><![CDATA[Menopausal Symptoms]]></category>
		<category><![CDATA[PMS and PMDD]]></category>
		<category><![CDATA[Center for Women's Mental Health]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[hormone replacement therapy]]></category>
		<category><![CDATA[HRT]]></category>
		<category><![CDATA[oral contraceptives]]></category>
		<category><![CDATA[perimenopause]]></category>
		<category><![CDATA[PMDD]]></category>
		<category><![CDATA[PMS]]></category>
		<category><![CDATA[side effects]]></category>
		<category><![CDATA[Yasmin]]></category>
		<category><![CDATA[Yaz]]></category>

		<guid isPermaLink="false">http://www.womensmentalhealth.org/?p=2130</guid>
		<description><![CDATA[The FDA will require Yaz, Yasmin and several other newer oral contraceptives to carry new warning labels that detail the potential risk of venous thromboembolism (VTE or blood clots).  All oral contraceptives increase the risk of blood clots; however, recent studies have suggested that birth control pills containing drospirenone, a synthetic form of the hormone [...]]]></description>
		<wfw:commentRss>http://www.womensmentalhealth.org/posts/yaz-and-other-oral-contraceptives-will-carry-a-new-warning-label/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Metformin May Help to Treat Menstrual Ireegularities in Women Treated with Antipsychotics</title>
		<link>http://www.womensmentalhealth.org/posts/metformin-may-help-to-treat-menstrual-ireegularities-in-women-treated-with-antipsychotics/</link>
		<comments>http://www.womensmentalhealth.org/posts/metformin-may-help-to-treat-menstrual-ireegularities-in-women-treated-with-antipsychotics/#comments</comments>
		<pubDate>Wed, 23 May 2012 15:53:40 +0000</pubDate>
		<dc:creator>MGH Center for Women's Mental Health</dc:creator>
				<category><![CDATA[Infertility and Mental Health]]></category>
		<category><![CDATA[PMS and PMDD]]></category>
		<category><![CDATA[antipsychotic medication]]></category>
		<category><![CDATA[antipsychotics]]></category>
		<category><![CDATA[atypical antipsychotics]]></category>
		<category><![CDATA[Center for Women's Mental Health]]></category>
		<category><![CDATA[menstrual cycle]]></category>
		<category><![CDATA[menstrual irregularity]]></category>
		<category><![CDATA[menstruation]]></category>
		<category><![CDATA[schizophrenia]]></category>
		<category><![CDATA[weight loss]]></category>

		<guid isPermaLink="false">http://www.womensmentalhealth.org/?p=2147</guid>
		<description><![CDATA[Menstrual irregularity is a common side effect of antipsychotic treatment in women, occurring more commonly in those treated with risperidone and the older antipsychotic medications.  New research presented at the APA earlier this month indicated that the addition of metformin at 500 mg bid resolved menstrual irregularities in most women treated with antipsychotic medications.  (Metformin [...]]]></description>
		<wfw:commentRss>http://www.womensmentalhealth.org/posts/metformin-may-help-to-treat-menstrual-ireegularities-in-women-treated-with-antipsychotics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Heavy Menstrual Bleeding More Common in Midlife Women with Histories of Depression</title>
		<link>http://www.womensmentalhealth.org/posts/heavy-menstrual-bleeding-more-common-in-midlife-women-with-histories-of-depression/</link>
		<comments>http://www.womensmentalhealth.org/posts/heavy-menstrual-bleeding-more-common-in-midlife-women-with-histories-of-depression/#comments</comments>
		<pubDate>Tue, 22 May 2012 08:11:22 +0000</pubDate>
		<dc:creator>MGH Center for Women's Mental Health</dc:creator>
				<category><![CDATA[Menopausal Symptoms]]></category>
		<category><![CDATA[Center for Women's Mental Health]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[estrogen]]></category>
		<category><![CDATA[hormones]]></category>
		<category><![CDATA[major depression]]></category>
		<category><![CDATA[menopausal symptoms]]></category>
		<category><![CDATA[menopause]]></category>
		<category><![CDATA[menstruation]]></category>
		<category><![CDATA[perimenopause]]></category>

		<guid isPermaLink="false">http://www.womensmentalhealth.org/?p=2134</guid>
		<description><![CDATA[Menstrual problems are common among premenopausal women and become more frequent with increasing reproductive age, especially just before and during perimenopause.  In the Study of Women&#8217;s Health Across the Nation, a multisite study of menopause and aging, information regarding menstrual history was collected in a total of 934 premenopausal and early perimenopausal women between the [...]]]></description>
		<wfw:commentRss>http://www.womensmentalhealth.org/posts/heavy-menstrual-bleeding-more-common-in-midlife-women-with-histories-of-depression/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Escitalopram (Lexapro) for Hot Flashes: No Significant Sexual Side Effects</title>
		<link>http://www.womensmentalhealth.org/posts/escitalopram-lexapro-for-hot-flashes-no-significant-sexual-side-effects/</link>
		<comments>http://www.womensmentalhealth.org/posts/escitalopram-lexapro-for-hot-flashes-no-significant-sexual-side-effects/#comments</comments>
		<pubDate>Mon, 21 May 2012 18:08:46 +0000</pubDate>
		<dc:creator>MGH Center for Women's Mental Health</dc:creator>
				<category><![CDATA[Menopausal Symptoms]]></category>
		<category><![CDATA[menopause]]></category>
		<category><![CDATA[antidepressants]]></category>
		<category><![CDATA[Center for Women's Mental Health]]></category>
		<category><![CDATA[escitalopram]]></category>
		<category><![CDATA[hot flashes]]></category>
		<category><![CDATA[Lexapro]]></category>
		<category><![CDATA[SSRI]]></category>
		<category><![CDATA[SSRIs]]></category>
		<category><![CDATA[vasomotor symptoms]]></category>

		<guid isPermaLink="false">http://www.womensmentalhealth.org/?p=2121</guid>
		<description><![CDATA[Escitalopram, when used in the treatment of menopausal vasomotor symptoms, did not worsen overall sexual function among non-depressed midlife women. Reviewed in Medscape Reed SD, Guthrie KA, Joffe H, Shifren JL, Seguin RA, Freeman EW.  Sexual Function in Nondepressed Women Using Escitalopram for Vasomotor Symptoms: A Randomized Controlled Trial.  Obstet Gynecol. 2012; 119(3):527-38.]]></description>
		<wfw:commentRss>http://www.womensmentalhealth.org/posts/escitalopram-lexapro-for-hot-flashes-no-significant-sexual-side-effects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Worse outcomes in Infants Exposed to MDMA (Ecstasy) during Pregnancy</title>
		<link>http://www.womensmentalhealth.org/posts/worse-outcomes-in-infants-exposed-to-mdma-ecstasy-during-pregnancy/</link>
		<comments>http://www.womensmentalhealth.org/posts/worse-outcomes-in-infants-exposed-to-mdma-ecstasy-during-pregnancy/#comments</comments>
		<pubDate>Sat, 19 May 2012 10:57:52 +0000</pubDate>
		<dc:creator>MGH Center for Women's Mental Health</dc:creator>
				<category><![CDATA[pregnancy]]></category>
		<category><![CDATA[Center for Women's Mental Health]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Ecstasy]]></category>
		<category><![CDATA[illicit drugs]]></category>
		<category><![CDATA[MDMA]]></category>
		<category><![CDATA[neonatal outcomes]]></category>

		<guid isPermaLink="false">http://www.womensmentalhealth.org/?p=2117</guid>
		<description><![CDATA[3,4-methylenedioxymethamphetamine (MDMA) or “Ecstasy” is one of the most widely used illicit recreational drugs among young adults. This report indicates that infants exposed to Ecstasy ad other recreational drugs may have delays in their motor development. This study is the first to prospectively identify MDMA-using women during pregnancy and to assess outcomes in their infants. [...]]]></description>
		<wfw:commentRss>http://www.womensmentalhealth.org/posts/worse-outcomes-in-infants-exposed-to-mdma-ecstasy-during-pregnancy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

